CTOs on the Move

Image Owl

www.imageowl.com

 
Image Owl creates complete, convenient , accurate and insightful cloud-based solutions to analyze and manage your diagnostic medical imaging and radiotherapy quality assurance needs.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.imageowl.com
  • 2727 State Route 29
    Greenwich, NY USA 12834
  • Phone: 518.692.0226

Executives

Name Title Contact Details

Similar Companies

BTG International

BTG is a global healthcare company focused on Interventional Medicine. Our innovative medical technology helps physicians treat their patients through minimally invasive procedures. Today we have a growing portfolio of products that advance the treatment of cancer, vascular conditions and severe emphysema. Our Pharmaceuticals business provides products that help patients overexposed to certain medications or toxins. Our mission is to provide imaginative new ways to treat disease; making a real difference for patients, and a valuable contribution to healthcare. As medicine moves from major surgery to minor procedure, no company endeavours to do more to help doctors in their quest to see more, reach further and treat smarter. We understand their needs and equip them with tools and techniques that would have seemed like science fiction only a generation ago. We invest in clinical evidence that helps demonstrate the value of our treatments to patients, doctors, and healthcare systems. With relentless curiosity we`ll work with clinicians to find elegant new ways to extend our power over disease and transform patient care. There are no limits to where our ideas will take us.

Pharmaka

Pharmaka is a Flemington, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

AKH

AKH is a Jacksonville, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

TriRivers Health Partners

TriRivers Health Partners is a Rockford, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Metamark

Metamark Genetics, Inc. is a privately held biotechnology company founded in 2007 to develop novel, function-based, prognostic and diagnostic tests aimed at improving cancer care. The company's proprietary genomic and proteomic discovery platforms have yielded significant discoveries in several disease areas, including prostate, colon, and breast cancers. In early 2014, Metamark plans to commercialize ProMark™—its prostate cancer prognostic test—through its Cambridge, Massachusetts CLIA-certified laboratory. For more information, please visit the company's Website at www.metamarkgenetics.com. Metamark™ and ProMark™ are trademarks of Metamark Genetics, Inc.